Cart
sales@molnova.com
MDVN-1003
CAS No. 2058116-54-2
MDVN-1003( MDVN1003 | MDVN 1003 )
Catalog No. M13199 CAS No. 2058116-54-2
A first-in-class, selective, orally bioavailable, dual inhibitor of BTK and PI3Kδ kinases with IC50 of 32.3 nM and 16.9 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMDVN-1003
-
NoteResearch use only, not for human use.
-
Brief DescriptionA first-in-class, selective, orally bioavailable, dual inhibitor of BTK and PI3Kδ kinases with IC50 of 32.3 nM and 16.9 nM, respectively.
-
DescriptionA first-in-class, selective, orally bioavailable, dual inhibitor of BTK and PI3Kδ kinases with IC50 of 32.3 nM and 16.9 nM, respectively; inhibits B cell activation upon BCR cross-linking ex vivo and in vivo, induces apoptosis and decreases viability of DOHH-2 cells; shows significant anti-tumor effects in an NHL xenograft model in mice.
-
In Vitro——
-
In Vivo——
-
SynonymsMDVN1003 | MDVN 1003
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2058116-54-2
-
Formula Weight417.45
-
Molecular FormulaC22H20FN7O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1COC2=C(N1)C=C(C=C2F)C3=NN(C4=NC=NC(=C34)N)C5CC6=C(C5)C=C(C=C6)N
-
Chemical Name1-(5-amino-2,3-dihydro-1H-inden-2-yl)-3-(8-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alfaro J, et al. J Pharmacol Exp Ther. 2017 May;361(2):312-321.
molnova catalog
related products
-
Vecabrutinib
Vecabrutinib (SNS-062) is a potent, reversible, non-covalent BTK inhibitor with IC50 of 2.9 and 4.4 nM for WT BTK and C481S BTK, respectively;
-
RN-486
A potent and selective BTK inhibitor with IC50 of 4 nM in the enzymatic assay; shows high selectivity against a panel of 369 kinases.
-
Poseltinib
Poseltinib (HM-71224, LY-3337641) is a potent and selective, covalent inhibitor of Btk with IC50 of 1.95 nM.
